Omaniscan (Gadodiamide Injection USP)
Omniscan (gadodiamide) injection for intravenous use
Omniscan (gadodiamide) injection is the formulation of the gadolinium complex of diethylenetriamine pentaacetic acid bismethylamide, and is an injectable, nonionic extracellular enhancing agent for magnetic resonance imaging. Omniscan is administered by intravenous injection.
The following adverse reactions are discussed in greater detail in other sections of the label
Nephrogenic systemic fibrosis [see warnings and precautions]
Hypersensitivity reactions [see warnings and precautions]
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
Developed and Managed by Infocom Network Private Limited.